Review



us optum de identified electronic health record data set  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Optum Inc us optum de identified electronic health record data set
    Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified <t>Electronic</t> Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
    Us Optum De Identified Electronic Health Record Data Set, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/us+optum+de+identified+electronic+health+record+data+set/electronic+health+records/pmc12317948-53-86-87
    Average 86 stars, based on 1 article reviews
    us optum de identified electronic health record data set - by Bioz Stars, 2026-09
    86/100 stars

    Images

    1) Product Images from "Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease"

    Article Title: Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

    Journal: Diabetes Therapy

    doi: 10.1007/s13300-025-01750-7

    Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
    Figure Legend Snippet: Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors

    Techniques Used: Filtration

    Related Articles

    Filtration:

    Article Title: Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease
    Article Snippet: This was a multidatabase, multinational cohort study aiming to describe the incidence of cardiorenal events in separate, non-mutually exclusive cohorts of patients with both CKD and T2D initiating therapy with either an SGLT2i or GLP-1 RA using secondary data from four participating data sources: two population-based data sources in Europe (Danish National Health Registers [DNHR] and Valencia Health System Integrated Database [VID] in Spain); one hospital-based CKD registry in Japan (Japan Chronic Kidney Disease Database Extension [J-CKD-DB-Ex]); and one electronic health record (EHR) database in the US (Optum ® de-identified Electronic Health Record data set [Optum ® EHR]).



    Similar Products

    us optum de identified electronic health record data set  (Optum Inc)
    86
    Optum Inc us optum de identified electronic health record data set
    Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified <t>Electronic</t> Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
    Us Optum De Identified Electronic Health Record Data Set, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/us+optum+de+identified+electronic+health+record+data+set/electronic+health+records/pmc12317948-53-86-87
    Average 86 stars, based on 1 article reviews
    us optum de identified electronic health record data set - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors

    Journal: Diabetes Therapy

    Article Title: Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

    doi: 10.1007/s13300-025-01750-7

    Figure Lengend Snippet: Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors

    Article Snippet: This was a multidatabase, multinational cohort study aiming to describe the incidence of cardiorenal events in separate, non-mutually exclusive cohorts of patients with both CKD and T2D initiating therapy with either an SGLT2i or GLP-1 RA using secondary data from four participating data sources: two population-based data sources in Europe (Danish National Health Registers [DNHR] and Valencia Health System Integrated Database [VID] in Spain); one hospital-based CKD registry in Japan (Japan Chronic Kidney Disease Database Extension [J-CKD-DB-Ex]); and one electronic health record (EHR) database in the US (Optum ® de-identified Electronic Health Record data set [Optum ® EHR]).

    Techniques: Filtration